Karlis Pauksens

Management of cytomegalovirus infections - Swedish recommendations 2023

Swartling, Lisa; Engman, Mona-Lisa; Eriksen, Jaran; Fischler, Bjoern et al.

Ingår i Infectious Diseases, s. 907-917, 2024

• DOI för Management of cytomegalovirus infections - Swedish recommendations 2023

Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies

Hammarstrom, Helena; Krifors, Anders; Athlin, Simon; Friman, Vanda et al.

Ingår i Clinical Infectious Diseases, 2023

• DOI för Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies
• Ladda ner fulltext (pdf) av Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies

A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients

Melin, Jan; Svensson, Maria K.; Albinsson, Bo; Winqvist, Ola et al.

Ingår i Upsala Journal of Medical Sciences, 2022

• DOI för A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients
• Ladda ner fulltext (pdf) av A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients

Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma: Can the response be predicted?

Ljunghill Hedberg, Anna; Pauksen, Karlis; Enblad, Per; Larsson, Anders et al.

Ingår i Human Vaccines & Immunotherapeutics, 2022

• DOI för Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma: Can the response be predicted?
• Ladda ner fulltext (pdf) av Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma: Can the response be predicted?

Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination

Hastie, Andrew; Catteau, Grégory; Enemuo, Adaora; Mrkvan, Tomas et al.

Ingår i Journal of Infectious Diseases, s. 2025-2034, 2021

• DOI för Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination
• Ladda ner fulltext (pdf) av Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination

Management of cytomegalovirus infections - Swedish recommendations 2023

Swartling, Lisa; Engman, Mona-Lisa; Eriksen, Jaran; Fischler, Bjoern et al.

Ingår i Infectious Diseases, s. 907-917, 2024

• DOI för Management of cytomegalovirus infections - Swedish recommendations 2023

Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies

Hammarstrom, Helena; Krifors, Anders; Athlin, Simon; Friman, Vanda et al.

Ingår i Clinical Infectious Diseases, 2023

• DOI för Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies
• Ladda ner fulltext (pdf) av Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies

A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients

Melin, Jan; Svensson, Maria K.; Albinsson, Bo; Winqvist, Ola et al.

Ingår i Upsala Journal of Medical Sciences, 2022

• DOI för A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients
• Ladda ner fulltext (pdf) av A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients

Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma: Can the response be predicted?

Ljunghill Hedberg, Anna; Pauksen, Karlis; Enblad, Per; Larsson, Anders et al.

Ingår i Human Vaccines & Immunotherapeutics, 2022

• DOI för Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma: Can the response be predicted?
• Ladda ner fulltext (pdf) av Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma: Can the response be predicted?

Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination

Hastie, Andrew; Catteau, Grégory; Enemuo, Adaora; Mrkvan, Tomas et al.

Ingår i Journal of Infectious Diseases, s. 2025-2034, 2021

• DOI för Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination
• Ladda ner fulltext (pdf) av Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination

COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial

Welen, Karin; Overby, Anna K.; Ahlm, Clas; Freyhult, Eva et al.

Ingår i Trials, 2021

• DOI för COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial
• Ladda ner fulltext (pdf) av COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial

Blood biomarker algorithms for the diagnosis of mycoplasma pneumoniae respiratory infections

Venge, Per; Eriksson, Staffan; Pauksen, Karlis

Ingår i JIM - Journal of Immunological Methods, 2021

• DOI för Blood biomarker algorithms for the diagnosis of mycoplasma pneumoniae respiratory infections
• Ladda ner fulltext (pdf) av Blood biomarker algorithms for the diagnosis of mycoplasma pneumoniae respiratory infections

Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders

Kinch, Amelie; Baecklund, Eva; Molin, Daniel; Pauksen, Karlis et al.

Ingår i Acta Oncologica, s. 771-778, 2021

• DOI för Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders
• Ladda ner fulltext (pdf) av Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders

High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19

Karawajczyk, Malgorzata; Douhan Håkansson, Lena; Lipcsey, Miklós; Hultström, Michael et al.

Ingår i Therapeutic advances in infectious disease, 2021

• DOI för High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19
• Ladda ner fulltext (pdf) av High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19

Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients

Melin, Jan; Svensson, Maria K.; Albinsson, Bo; Winqvist, Ola et al.

Ingår i BMC Immunology, 2021

• DOI för Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
• Ladda ner fulltext (pdf) av Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients

Calprotectin, a new biomarker for diagnosis of acute respiratory infections

Havelka, Aleksandra; Sejersen, Kristina; Venge, Per; Pauksens, Karlis et al.

Ingår i Scientific Reports, 2020

• DOI för Calprotectin, a new biomarker for diagnosis of acute respiratory infections
• Ladda ner fulltext (pdf) av Calprotectin, a new biomarker for diagnosis of acute respiratory infections

Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting

Joona, Therse Bjorkin; Digkas, Evangelos; Wennstig, Anna-Karin; Nystrom, Karin et al.

Ingår i Breast Cancer Research and Treatment, s. 45-52, 2020

• DOI för Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
• Ladda ner fulltext (pdf) av Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting

Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

Oostvogels, Lidia; Heineman, Thomas C.; Johnson, Robert W.; Levin, Myron J. et al.

Ingår i Human Vaccines & Immunotherapeutics, s. 2865-2872, 2019

• DOI för Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials
• Ladda ner fulltext (pdf) av Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

HNL (Human Neutrophil Lipocalin) and a multimarker approach to the distinction between bacterial and viral infections

Venge, Per; Eriksson, Ann-Katrin; Holmgren, Sofia; Douhan Håkansson, Lena et al.

Ingår i JIM - Journal of Immunological Methods, 2019

• DOI för HNL (Human Neutrophil Lipocalin) and a multimarker approach to the distinction between bacterial and viral infections

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Lopez-Fauqued, Marta; Campora, Laura; Delannois, Frederique; El Idrissi, Mohamed et al.

Ingår i Vaccine, s. 2482-2493, 2019

• DOI för Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials
• Ladda ner fulltext (pdf) av Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Wirksamkeit, Immunogenität und Sicherheit eines adjuvantierten Herpes Zoster-Virus Untereinheiten-Impfstoffkandidaten bei Erwachsenen ab 60 Jahren und älter: Ergebnisse aus den Wirksamkeitsstudien ZOE-50 und ZOE-70

McElhaney, Janet; Lal, Himal; Cunningham, Anthony; Levin, Myron et al.

Ingår i Der Internist, 2018

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

Cunningham, Anthony L.; Heineman, Thomas C.; Lal, Himal; Godeaux, Olivier et al.

Ingår i Journal of Infectious Diseases, s. 1750-1760, 2018

• DOI för Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
• Ladda ner fulltext (pdf) av Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT

Kinch, Amelie; Hallböök, Helene; Arvidson, Johan; Sällström, Kalle et al.

Ingår i Leukemia and Lymphoma, s. 1172-1179, 2018

• DOI för Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT

Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab

Knight, Ann; Pauksen, Karlis; Nordmark, Gunnel; Eva, Kumlien

Ingår i Rheumatology, s. 855-856, 2017

• DOI för Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab

Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery

Ljunghill Hedberg, Anna; Pauksens, Karlis; Enblad, Per; Söderberg, Jessika et al.

Ingår i Vaccine, s. 909-915, 2017

• DOI för Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery

Epstein-Barr virus-related disease after allogeneic HSCT and use of pre-emptive rituximab: Clinical Features And Outcome

Kinch, Amelie; Hallböök, Helene; Arvidson, Johan; Sällström, K. et al.

Ingår i Bone Marrow Transplantation, 2017

• DOI för Epstein-Barr virus-related disease after allogeneic HSCT and use of pre-emptive rituximab: Clinical Features And Outcome

Human Neutrophil Lipocalin in Activated Whole Blood Is a Specific and Rapid Diagnostic Biomarker of Bacterial Infections in the Respiratory Tract

Venge, Per; Eriksson, Ann-Katrin; Douhan Håkansson, Lena; Pauksen, Karlis

Ingår i Clinical and Vaccine Immunology, 2017

• DOI för Human Neutrophil Lipocalin in Activated Whole Blood Is a Specific and Rapid Diagnostic Biomarker of Bacterial Infections in the Respiratory Tract

Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study

Hertzell, Katarina Brodin; Pauksens, Karlis; Rombo, Lars; Knight, Ann et al.

Ingår i Vaccine, s. 650-655, 2016

• DOI för Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study

Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults

Chlibek, Roman; Pauksens, Karlis; Rombo, Lars; van Rijckevorsel, Gini et al.

Ingår i Vaccine, s. 863-868, 2016

• DOI för Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults
• Ladda ner fulltext (pdf) av Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults

Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study

Hallböök, Helene; Lidström, Anna-Karin; Pauksens, Karlis

Ingår i INFECTIOUS DISEASES, s. 443-448, 2016

• DOI för Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study

Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders: Clinical Features and Survival Outcomes

Berglund, David; Kinch, Amelie; Edman, Elin; Backlin, Carin et al.

Ingår i Transplantation, s. 1036-1042, 2015

• DOI för Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders: Clinical Features and Survival Outcomes

Lower response to early T-cell-dependent vaccination after neurotrauma or neurosurgery in adults

Ljunghill Hedberg, Anna; Pauksen, Karlis; Ronne-Engström, Elisabeth; Lundberg, Maria et al.

Ingår i Journal of Infection, s. 577-584, 2015

• DOI för Lower response to early T-cell-dependent vaccination after neurotrauma or neurosurgery in adults

Human Neutrophil Lipocalin as a Superior Diagnostic Means To Distinguish between Acute Bacterial and Viral Infections

Venge, Per; Douhan Håkansson, Lena; Garwicz, Daniel; Peterson, Christer et al.

Ingår i Clinical and Vaccine Immunology, s. 1025-1032, 2015

• DOI för Human Neutrophil Lipocalin as a Superior Diagnostic Means To Distinguish between Acute Bacterial and Viral Infections
• Ladda ner fulltext (pdf) av Human Neutrophil Lipocalin as a Superior Diagnostic Means To Distinguish between Acute Bacterial and Viral Infections

Human neutrophil lipocalin in fMLP-activated whole blood as a diagnostic means to distinguish between acute bacterial and viral infections

Venge, Per; Douhan, Lena Håkansson; Garwicz, Daniel; Peterson, Christer et al.

Ingår i JIM - Journal of Immunological Methods, s. 85-90, 2015

• DOI för Human neutrophil lipocalin in fMLP-activated whole blood as a diagnostic means to distinguish between acute bacterial and viral infections

Lower response to early T-cell-dependent vaccination after neurotrauma or neurosurgery in adults.

Ljunghill Hedberg, Anna; Pauksens, Karlis; Ronne-Engström, Elisabeth; Lundberg, Maria et al.

Ingår i Journal of Infection, s. 577-584, 2015

Donor or Recipient Origin of Posttransplant Lymphoproliferative Disorders Following Solid Organ Transplantation

Kinch, Amelie; Cavelier, Lucia; Bengtsson, Mats; Baecklund, Eva et al.

Ingår i American Journal of Transplantation, s. 2838-2845, 2014

• DOI för Donor or Recipient Origin of Posttransplant Lymphoproliferative Disorders Following Solid Organ Transplantation

Randomized Controlled Study of the Safety and Immunogenicity of Pneumococcal Vaccine Formulations Containing PhtD and Detoxified Pneumolysin with Alum or Adjuvant System AS02(V) in Elderly Adults

Pauksens, Karlis; Nilsson, Anna C.; Caubet, Magalie; Pascal, Thierry G. et al.

Ingår i Clinical and Vaccine Immunology, s. 651-660, 2014

• DOI för Randomized Controlled Study of the Safety and Immunogenicity of Pneumococcal Vaccine Formulations Containing PhtD and Detoxified Pneumolysin with Alum or Adjuvant System AS02(V) in Elderly Adults

A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.

Kinch, Amelie; Baecklund, Eva; Backlin, Carin; Ekman, Tor et al.

Ingår i Acta Oncologica, s. 669-679, 2014

• DOI för A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.

Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study

Chlibek, Roman; Smetana, Jan; Pauksens, Karlis; Rombo, Lars et al.

Ingår i Vaccine, s. 1745-1753, 2014

• DOI för Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study

The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab

Berglund, Åke; Willen, Linda; Grodeberg, Lina; Skattum, Lillemor et al.

Ingår i Acta Oncologica, s. 1212-1220, 2014

• DOI för The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab

Long-term follow-up in patients with HIV vaccinated with pandemic influenza A(H1N1)/09 AS03-adjuvanted split virion vaccine and seasonal trivalent influenza split virion vaccine

Pauksens, Karlis

Ingår i Infection Ecology & Epidemiology, s. 20766, 2013

• DOI för Long-term follow-up in patients with HIV vaccinated with pandemic influenza A(H1N1)/09 AS03-adjuvanted split virion vaccine and seasonal trivalent influenza split virion vaccine

Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

Rumke, Hans C.; Richardus, Jan Hendrik; Rombo, Lars; Pauksens, Karlis et al.

Ingår i BMC Infectious Diseases, s. 348, 2013

• DOI för Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial
• Ladda ner fulltext (pdf) av Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients

Cherif, Honar; Höglund, Martin; Pauksens, Karlis

Ingår i European Journal of Haematology, s. 413-419, 2013

• DOI för Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Jackson, Lisa A.; Gurtman, Alejandra; Rice, Kathryn; Pauksens, Karlis et al.

Ingår i Vaccine, s. 3585-3593, 2013

• DOI för Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Clinical and epidemiological findings in patients with pandemic A (H1N1) 2009 influenza in uppsala county, Sweden

Sylvan, Staffan; Christenson, Brith; Pauksens, Karlis; Berglund, Lars

Ingår i Research Journal of Infectious Diseases, 2013

• DOI för Clinical and epidemiological findings in patients with pandemic A (H1N1) 2009 influenza in uppsala county, Sweden

Influenza A H1N1 2009 Vaccine in Patients with Hematological Diseases: Good Safety and Immunogenicity Even in Heavily Chemotherapy-Treated Patients

Cherif, Honar; Höglund, Martin; Pauksens, Karlis

Ingår i Blood, s. 1054, 2012

Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: Results from the EBMT IDWP01 trial

Cordonnier, Catherine; Labopin, Myriam; Chesnel, Virginie; Ribaud, Patricia et al.

Ingår i Vaccine, s. 2730-2734, 2010

• DOI för Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: Results from the EBMT IDWP01 trial

Tissue localization and the establishment of a sensitive immunoassay of the newly discovered human phospholipase B-precursor (PLB-P)

Xu, Shengyuan; Cai, Linjun; Zhao, Linshu; Douhan-Håkansson, Lena et al.

Ingår i JIM - Journal of Immunological Methods, s. 71-77, 2010

• DOI för Tissue localization and the establishment of a sensitive immunoassay of the newly discovered human phospholipase B-precursor (PLB-P)

Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation

Cordonnier, Catherine; Labopin, Myriam; Chesnel, Virginie; Ribaud, Patricia et al.

Ingår i Clinical Infectious Diseases, s. 1392-1401, 2009

• DOI för Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation

Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity

Christenson, Brith; Pauksen, Karlis; Sylvan, Staffan P. E.

Ingår i Virology Journal, s. 52, 2008

• DOI för Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity

Neutrophil and monocyte receptor expression in uncomplicated and complicated influenza A infection with pneumonia

Pauksens, Karlis; Fjaertoft, Gustav; Douhan-Håkansson, Lena; Venge, Per

Ingår i Scandinavian Journal of Infectious Diseases, s. 326-37, 2008

• DOI för Neutrophil and monocyte receptor expression in uncomplicated and complicated influenza A infection with pneumonia

Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction

Kinch, Amelie; Öberg, Gunnar; Arvidson, Johan; Falk, Kerstin I. et al.

Ingår i Scandinavian Journal of Infectious Diseases, s. 235-244, 2007

• DOI för Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction

Dynamics of the immune response against extracellular products of group A streptococci during infection

Maripuu, Linda; Eriksson, Anna; Eriksson, Björn; Pauksens, Karlis et al.

Ingår i Clinical and Vaccine Immunology, s. 44-51, 2007

• DOI för Dynamics of the immune response against extracellular products of group A streptococci during infection

Human cell lines used in a micro neutralization test for measuring influenza-neutralizing antibodies

Mittelholzer, Camilla M.; Brokstad, K. A.; Pauksens, Karlis; Jonsson, R. et al.

Ingår i Scandinavian Journal of Immunology, s. 257-263, 2006

• DOI för Human cell lines used in a micro neutralization test for measuring influenza-neutralizing antibodies

Concomitant invasive pulmonary aspergillosis and aspergillus sinusitis in a patient with acute leukaemia

Pauksens, Karlis; Oberg, Gunnar

Ingår i Acta bio-medica : Atenei Parmensis, s. 23-25, 2006

Cell surface expression of FcgammaRI (CD64) on neutrophils and monocytes in patients with influenza A, with and without complications

Fjaertoft, Gustav; Pauksens, Karlis; Håkansson, Lena; Xu, Shengyuan et al.

Ingår i Scandinavian Journal of Infectious Diseases, s. 882-889, 2005

• DOI för Cell surface expression of FcgammaRI (CD64) on neutrophils and monocytes in patients with influenza A, with and without complications

Low utilisation of unactivated protein C in a patient with meningococcal septic shock and disseminated intravascular coagulation

Lignell, Anders; Siegbahn, Agneta; Stridsberg, Mats; Pauksen, Karlis et al.

Ingår i Acta Anaesthesiologica Scandinavica, s. 897-900, 2003

• DOI för Low utilisation of unactivated protein C in a patient with meningococcal septic shock and disseminated intravascular coagulation

Treatment and prevention of influenza: Swedish recommendations

Uhnoo, Ingrid; Linde, Annika; Pauksens, Karlis; Lindberg, Anders et al.

Ingår i Scandinavian Journal of Infectious Diseases, s. 3-11, 2003

• DOI för Treatment and prevention of influenza: Swedish recommendations

Skin infection caused by Mycobacterium szulgai after allogenic bone marrow transplantation

Frisk, Per; Boman, Gunnar; Pauksen, Karlis; Petrini, B. et al.

Ingår i Bone Marrow Transplantation, s. 511-513, 2003

• DOI för Skin infection caused by Mycobacterium szulgai after allogenic bone marrow transplantation

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Ljungman, P.; Ward, K. N.; Crooks, B. N.; Parker, A. et al.

Ingår i Bone Marrow Transplantation, s. 479-484, 2001

Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients

Pauksen, Karlis; Linde, Annika; Hammarström, Viera; Sjölin, Jan et al.

Ingår i Clinical Infectious Diseases, s. 342-348, 2000

• DOI för Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients

Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients

Hammarström, Viera; Pauksen, Karlis; Svensson, H.; Lönnqvist, B. et al.

Ingår i Transplantation, s. 1582-1586, 2000

Subsets of T-cells and in vitro cytokine production after measles and varicellae-zoster virus antigen stimulation in allogeneic BMT patients

Pauksen, Karlis; Sjölin, Jan; Linde, Annika; Andersson, Birger et al.

Ingår i Scandinavian Journal of Infectious Diseases, s. 43-49, 1999

Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients

Hammarström, Viera; Pauksen, Karlis; Björkstrand, B.; Simonsson, Bengt et al.

Ingår i Bone Marrow Transplantation, s. 67-71, 1998

Tetanus immunity in patients with hematological malignancies

Hammarström, Viera; Pauksen, Karlis; Svensson, H.; Öberg, G. et al.

Ingår i Supportive Care in Cancer, s. 469-472, 1998

Th1 and Th2 cytokine response after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination

Pauksen, Karlis; Sjölin, Jan; Linde, Annika; Alm, G. et al.

Ingår i Bone Marrow Transplantation, s. 317-323, 1997

Antiviral treatment with WIN 54954 reduces mortality in murine Coxsackie virus B3 myocarditis

Fohlman, Jan; Pauksen, Karlis; Hyypiä, T.; Eggertsen, G. et al.

Ingår i Circulation, s. 2254-2259, 1996

Foscarnet for pre-emptive therapy of CMV infection detected by a leukocyte-based nested PCR in allogeneic bone marrow transplant patients

Ljungman, P.; Öberg, G.; Aschan, J.; Ehrnst, A. et al.

Ingår i Bone Marrow Transplantation, s. 565-568, 1996

Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections

Norrby-Teglund, Anna; Pauksen, Karlis; Norgren, Mari; Holm, Stig

Ingår i Scandinavian Journal of Infectious Diseases, s. 125-130, 1995

Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections

Xu, S. Y.; Pauksen, Karlis; Venge, Per

Ingår i Scandinavian Journal of Clinical and Laboratory Investigation, s. 125-131, 1995

The differential release of eosinophil granule proteins: Studies on patients with acute bacterial and viral infections

Karawajczyk, G.; Pauksen, Karlis; Peterson, C.G.; Eklund, E. et al.

Ingår i Clinical and Experimental Allergy, s. 713-719, 1995